Spruce Biosciences, Inc. (SPRB) stock
SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$43.31+0.42 (+0.98%)
Close on Nov 13, 2026Market cap $124.47MP/E –Yield –
Spruce Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Spruce Biosciences's profit margin for the twelve months ending Sep 30, 2025 was -6869.3%. For fiscal 2024 it was -1079.9%, against -475.0% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -1079.9% | −605.0 |
| FY2023 | Dec 31, 2023 | -475.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -3380.1% | −3035.4 |
| Q3 FY2024 | Sep 30, 2024 | -1440.4% | −1038.3 |
| Q2 FY2024 | Jun 30, 2024 | -570.2% | +22.1 |
| Q1 FY2024 | Mar 31, 2024 | -580.7% | +70.6 |
| Q4 FY2023 | Dec 31, 2023 | -344.6% | – |
| Q3 FY2023 | Sep 30, 2023 | -402.0% | – |
| Q2 FY2023 | Jun 30, 2023 | -592.3% | – |
| Q1 FY2023 | Mar 31, 2023 | -651.3% | – |
See a number that looks wrong?